コレステロール検査の市場規模、シェア、成長分析：製品別、テスト別、年齢層別、用途別、流通チャネル別、地域別 - 産業予測、2025年～2032年

コレステロール検査の世界市場規模は、2023年に73億7,000万米ドルと評価され、2024年の79億9,000万米ドルから2032年には152億3,000万米ドルに成長し、予測期間（2025～2032年）のCAGRは8.4％で成長する見通しです。

コレステロール検査市場は、主に生活習慣関連疾患の増加と、座りがちな生活習慣や肥満による心血管障害の有病率の増加によって、上昇基調にあります。定期的なスクリーニングと検診は、市販の検査キットの利便性と小型化された電子機器のような技術の進歩とともに、需要をさらに促進しています。さらに、高コレステロールや関連疾患のリスクが高い高齢化も市場拡大に大きく寄与しています。ヘルスケアイニシアチブと教育キャンペーンに支えられた予防ヘルスケアに対する人々の意識の高まりが、日常的なコレステロールモニタリングを後押ししています。しかし、診断ラボの不足、規制上のハードル、発展途上地域における熟練した専門家の不足といった課題も存在します。このような制約にもかかわらず、ヘルスケアへの投資や技術革新を通じて機会が生まれ、ダイナミックな市場情勢が期待されています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析

コレステロール検査市場規模：製品別& CAGR（2025-2032）

• 市場概要
• 検査キット
• 検査ストリップ
• その他

コレステロール検査市場規模：テスト別& CAGR（2025-2032）

• 市場概要
• 総コレステロール検査
• 高密度リポタンパク質（HDL）コレステロール検査
• 低密度リポタンパク質（LDL）コレステロール検査
• トリグリセリド検査
• その他

コレステロール検査市場規模：年齢層別& CAGR（2025-2032）

• 市場概要
• 高齢者
• 成人
• 小児

コレステロール検査市場規模：用途別& CAGR（2025-2032）

• 市場概要
• 心血管疾患
• 糖尿病
• 肥満
• 高脂血症
• その他

コレステロール検査市場規模：流通チャネル別& CAGR（2025-2032）

• 市場概要
• 店頭
• 処方箋

コレステロール検査市場規模：サービスプロバイダー別& CAGR（2025-2032）

• 市場概要
• 病院と診療所
• 診断検査室
• 外来診療センター
• その他

コレステロール検査市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• Abbott Laboratories（USA）
• F. Hoffmann-La Roche Ltd.（Switzerland）
• Siemens Healthineers AG（Germany）
• Thermo Fisher Scientific Inc.（USA）
• Danaher Corporation（USA）
• PerkinElmer, Inc.（USA）
• Bio-Rad Laboratories, Inc.（USA）
• Randox Laboratories Ltd.（UK）
• Eurofins Scientific（Luxembourg）
• Novartis AG（Switzerland）
• Merck KGaA（Germany）
• Beckman Coulter Inc.（USA）
• Boston Heart Diagnostics Corporation（USA）
• Quest Diagnostics Incorporated（USA）
• Laboratory Corporation of America Holdings（Labcorp）（USA）
• QuidelOrtho Corporation（USA）
• Helena Laboratories Corporation（USA）
• Sekisui Chemical Co., Ltd.（Japan）
• Sinocare Inc.（China）

結論と推奨事項

Global Cholesterol Test Market size was valued at USD 7.37 billion in 2023 and is poised to grow from USD 7.99 billion in 2024 to USD 15.23 billion by 2032, growing at a CAGR of 8.4% during the forecast period (2025-2032).

The cholesterol testing market is on an upward trajectory, primarily fueled by rising lifestyle-related diseases and the growing prevalence of cardiovascular disorders due to sedentary habits and obesity. Regular screenings and checkups, alongside the convenience of over-the-counter test kits and technological advancements like miniaturized electronics, are further propelling demand. Additionally, the aging population, which faces higher risks of high cholesterol and related conditions, significantly contributes to market expansion. Increased public awareness of preventive healthcare, supported by healthcare initiatives and educational campaigns, drives routine cholesterol monitoring. However, challenges such as a lack of diagnostic labs, regulatory hurdles, and the shortage of skilled professionals in developing regions exist. Despite these constraints, opportunities arise through healthcare investments and technological innovation, promising a dynamic market landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cholesterol Test market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cholesterol Test Market Segmental Analysis

Global Cholesterol Test Market is segmented by Product, Test, Age Group, Application, Distribution Channel, Service Provider and region. Based on Product, the market is segmented into Testing Kits, Testing Strips and Others. Based on Test, the market is segmented into Total Cholesterol Tests, High Density Lipoprotein (HDL) Cholesterol Tests, Low Density Lipoprotein (LDL) Cholesterol Tests, Triglyceride Tests and Others. Based on Age Group, the market is segmented into Geriatric, Adult and Pediatric. Based on Application, the market is segmented into Cardiovascular Diseases, Diabetes, Obesity, Hyperlipidemia and Others. Based on Distribution Channel, the market is segmented into Over the Counter and Prescription Based. Based on Service Provider, the market is segmented into Hospitals and Clinics, Diagnostic Laboratories, Ambulatory Care Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cholesterol Test Market

The global cholesterol test market is significantly influenced by the rising prevalence of cardiovascular diseases, such as heart disease and stroke, which continue to be the primary contributors to global morbidity and mortality rates. As awareness of the link between cholesterol levels and cardiovascular health increases, the necessity for cholesterol testing as a critical component of risk assessment profoundly enhances the demand for various cholesterol testing products and services. This growing emphasis on preventive healthcare and early detection plays a vital role in the expansion of the cholesterol testing market, motivating individuals and healthcare professionals to prioritize regular testing in their health management strategies.

Restraints in the Global Cholesterol Test Market

One of the major constraints affecting the Global Cholesterol Test market is the financial burden associated with cholesterol testing. In areas with inadequate healthcare infrastructure or for individuals without insurance, the expense of these tests can be prohibitive. This high cost may discourage many patients, particularly those from lower socioeconomic backgrounds, from seeking regular cholesterol screenings. Consequently, this limitation can hinder the overall market growth and accessibility of necessary health evaluations, resulting in untreated cardiovascular issues and related health complications in populations that are already vulnerable. Addressing these cost barriers is crucial for enhancing screening rates and improving public health outcomes.

Market Trends of the Global Cholesterol Test Market

The Global Cholesterol Test market is experiencing a significant transformation driven by advancements in testing technologies. Emerging innovations like point-of-care devices, non-invasive methods, and high-sensitivity assays are leading to more accurate, efficient, and accessible cholesterol assessments. Additionally, the integration of cholesterol testing with digital health solutions, electronic health records (EHRs), and telemedicine platforms is enhancing the landscape, facilitating remote monitoring and improved patient engagement. This convergence not only streamlines data management but also optimizes cholesterol management strategies across diverse healthcare settings, positioning the market for robust growth as healthcare increasingly embraces technology-driven solutions.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Cholesterol Test Market Size by Product & CAGR (2025-2032)

• Market Overview
• Testing Kits
• Testing Strips
• Others

Global Cholesterol Test Market Size by Test & CAGR (2025-2032)

• Market Overview
• Total Cholesterol Tests
• High Density Lipoprotein (HDL) Cholesterol Tests
• Low Density Lipoprotein (LDL) Cholesterol Tests
• Triglyceride Tests
• Others

Global Cholesterol Test Market Size by Age Group & CAGR (2025-2032)

• Market Overview
• Geriatric
• Adult
• Pediatric

Global Cholesterol Test Market Size by Application & CAGR (2025-2032)

• Market Overview
• Cardiovascular Diseases
• Diabetes
• Obesity
• Hyperlipidemia
• Others

Global Cholesterol Test Market Size by Distribution Channel & CAGR (2025-2032)

• Market Overview
• Over the Counter
• Prescription Based

Global Cholesterol Test Market Size by Service Provider & CAGR (2025-2032)

• Market Overview
• Hospitals and Clinics
• Diagnostic Laboratories
• Ambulatory Care Centers
• Others

Global Cholesterol Test Market Size & CAGR (2025-2032)

• North America (Product, Test, Age Group, Application, Distribution Channel, Service Provider)
  • US
  • Canada
• Europe (Product, Test, Age Group, Application, Distribution Channel, Service Provider)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Test, Age Group, Application, Distribution Channel, Service Provider)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Test, Age Group, Application, Distribution Channel, Service Provider)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Test, Age Group, Application, Distribution Channel, Service Provider)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Randox Laboratories Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beckman Coulter Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Heart Diagnostics Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quest Diagnostics Incorporated (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Laboratory Corporation of America Holdings (Labcorp) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QuidelOrtho Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Helena Laboratories Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sekisui Chemical Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sinocare Inc. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations